PPD

Wilmington, United States Founded: 1985 • Age: 41 yrs Acquired By Thermo Fisher Scientific
CRO providing diversified clinical development services
Annual revenue $51.4M Latest available
Total funding - 6 rounds
Employees 1674 Tracked headcount
Investors 3 Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About PPD

PPD is a company based in Wilmington (United States) founded in 1985 was acquired by Thermo Fisher Scientific in April 2021. The company has 1,674 employees as of April 01, 2024. PPD has completed 9 acquisitions, including AbCRO, Acurian and Bioduro. PPD offers products and services including Clinical Development Services, Laboratory Services, and Functional Service Partnerships. PPD operates in a competitive market with competitors including Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings, DM Clinical and IPHARMA, among others.

  • Headquarter Wilmington, United States
  • Employees 1674 as on 01 Apr, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ppd Pharmaceutical Development India Private Limited
  • Date of Incorporation 10 Feb, 2004
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $51.35 M (USD)
    32.53
    as on Mar 31, 2023
  • Net Profit
    $4.75 M (USD)
    16.14
    as on Mar 31, 2023
  • EBITDA
    $10.94 M (USD)
    66.12
    as on Mar 31, 2023
  • Latest Funding Round
    $126.5 M (USD), Grant

    Oct 13, 2023

  • Investors
  • Employee Count
    1674

    as on Apr 01, 2024

  • Investments & Acquisitions
    AbCRO

    & 8 more

  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PPD

PPD offers a comprehensive portfolio of products and services, including Clinical Development Services, Laboratory Services, and Functional Service Partnerships.

Product name locked
Category locked
Primary

Manages phases of clinical trials for drug efficacy

Product name locked
Category locked
Locked

Provides bioanalytical and biomarker testing for trials

Product name locked
Category locked
Locked

Offers specialized project management for biotech needs

People of PPD

Headcount 10000+
Employee Profiles 548
Employee Profiles
People
Daniel Schuler
Associate Manager Clinical Operations
People
Christina Ford
Clinical Manager
People
Claudia Deveras
Vice President Innovation & Operations Excellence
People
Mark Milliken
Senior Manager, Clinical Operations

Unlock access to complete

Funding Insights of PPD

Investors in PPD

PPD has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Thermo Fisher Scientific, HHS and Hellman & Friedman.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Electron microscopy services and microanalysis instruments are provided.
Locked Locked Locked
Premium access

Investor details for PPD

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by PPD

PPD has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include AbCRO, Acurian and Bioduro.

Investments
Premium access

Investment portfolio details for PPD

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Evidence-based solutions are provided for biopharmaceutical real-world effectiveness and safety.
Locked Locked 2012 Locked
Inappropriate content
Locked Locked 2009 Locked
Small molecule drug discovery platform is provided to researchers.
Locked Locked 2009 Locked
Premium access

Complete acquisition details for PPD

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - PPD

Premium access

Detailed financials for PPD

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ppd Comparisons

PPD Primary company
Description
CRO providing diversified clinical development services
Location
Wilmington, United States
Founded Year
1985
Annual Revenue
$51.35 M (USD)
Net Profit
$4.75 M (USD)
EBITDA
$10.94 M (USD)
Employees
1,674
As of 2024
Premium access

Peer comparison for PPD

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of PPD

PPD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cambrian BioPharma, Medicus Pharma, H.U. Group Holdings, DM Clinical and IPHARMA, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Medicines and therapies are developed for healthcare applications.
Locked Locked Locked
Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry
Locked Locked Locked
Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.
Locked Locked Locked
Conducts Phase I-IV clinical trials connecting patients with physicians for medical research.
Locked Locked Locked
Serves as a contract research organization focused on drug clinical trials.
Premium access

Detailed competitors of PPD

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ppd

Premium access

Complete news archive for PPD

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PPD

PPD was founded in 1985 and raised its 1st funding round 20 years after it was founded.

PPD is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

As of Apr 01, 2024, the latest employee count at PPD is 1,674.

Annual revenue of PPD is $51.35M as on Mar 31, 2023.

PPD, based in Wilmington, focuses on providing healthcare solutions, biopharma outsourcing, cro, and clinical development. CRO providing diversified clinical development services. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

PPD's top competitors include Cambrian BioPharma, Medicus Pharma and H.U. Group Holdings.

PPD offers Clinical Development Services, Laboratory Services, and Functional Service Partnerships.

PPD has made 9 acquisitions, including AbCRO, Acurian, and Bioduro.

PPD has 3 investors. Key investors include Thermo Fisher Scientific, HHS, and Hellman & Friedman.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available